Browsing Category

65338 posts

Acer Expands Lineup of Aspire AI Copilot+ PCs With New Laptops and All-in-Ones

Editor’s Summary The Acer Aspire X 16 AI laptop includes up to…
NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY

NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY

NYSE issues a pre-market daily advisory direct from the trading floor. NEW…
SKIA HEAD: AR Surgical Guidance Receives FDA 510(k) Clearance, Eyes U.S. Expansion with Structure Partnership

SKIA HEAD: AR Surgical Guidance Receives FDA 510(k) Clearance, Eyes U.S. Expansion with Structure Partnership

SEOUL, South Korea, May 29, 2026 /PRNewswire/ — South Korea-based medtech innovator SKIA…
Creality Falcon T1 5-in-1 Laser Engraver Now Available — Top Creators Put It to the Test

Creality Falcon T1 5-in-1 Laser Engraver Now Available — Top Creators Put It to the Test

The world’s first five-in-one laser workstation, validated by creators worldwide. Presale Offer…
INPARADISE Partners with Michelin Guide-Recommended Chef Daniel Sanz Martin for an Exclusive Culinary Collaboration

INPARADISE Partners with Michelin Guide-Recommended Chef Daniel Sanz Martin for an Exclusive Culinary Collaboration

【Taste the World, INPARADISE】Chapter Two: Spain Reinterpreting the Flavors of Spain Through…
Azazie Expands Texas Pop-Up Tour Across Houston, Dallas, Austin & San Antonio

Azazie Expands Texas Pop-Up Tour Across Houston, Dallas, Austin & San Antonio

The leading bridal and occasionwear brand continues its rapid Texas expansion with immersive…

Holmusk Expands NeuroBlu to 46 Million Patients, Adding Depth and Biomarker Data Across Neurology and Behavioral Health

Expansion anchored by two top neurological health systems, structured AD biomarker data,…

Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer

ZEGFROVY® demonstrated superior anti-tumor efficacy compared to platinum-doublet chemotherapy as a first-line…